According to Intercept Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -59.02%. At the end of 2021 the company had an Operating Margin of -25.15%.
Year | Operating Margin | Change |
---|---|---|
2021 | -25.15% | -71.39% |
2020 | -87.91% | -35.73% |
2019 | -136.78% | -20.47% |
2018 | -171.99% | -37.5% |
2017 | -275.18% | -83.37% |
2016 | -1,654.56% | -79.67% |
2015 | -8,139.07% | -49.95% |
2014 | -16,262.23% | 289% |
2013 | -4,180.52% | 134.31% |
2012 | -1,784.19% | 132.87% |
2011 | -766.17% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
24.84% | -142.09% | ๐บ๐ธ USA | |
-14.50% | -75.43% | ๐บ๐ธ USA | |
0.62% | -101.05% | ๐บ๐ธ USA | |
-856.84% | 1,351.78% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.